Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Hematologic DiseasesAnemia, Sickle CellBeta-ThalassemiaHematopoietic Stem Cell Transplantation
Interventions
DRUG

Sangstat

DRUG

Cyclophosphamide

DRUG

Busulfan

DRUG

Mycophenolate Mofetil

DRUG

Cyclosporine

PROCEDURE

Cord Blood Transplantation

Trial Locations (15)

19104

Children's Hospital Philadelphia, Philadelphia

29403

Medical University of South Carolina, Charleston

32207

Nemours Children's Clinic, Jacksonville

33136

University of Miami Batchelor Children's Research Center, Miami

48109

University of Michigan, Ann Arbor

60614

Children's Memorial Hospital, Chicago

75235

University of Texas Southwestern Medical Center - Dallas, Dallas

78229

Texas Transplant Institute, San Antonio

94609

Children's Hospital Oakland, Oakland

Children's Hospital, Oakland, Oakland

Unknown

Children's National Medical Center, Washington D.C.

Louisiana State University Children's Medical Center, New Orleans

Duke University Medical Center Children's Hospital, Durham

Hopital Ste-Justine, Montreal

07601

Hackensack University Medical Center, Hackensack

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00029380 - Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia | Biotech Hunter | Biotech Hunter